English 
Español 
News
El MINSA aprobó el Documento Técnico: Manual de Buenas Prácticas de Farmacovigilancia
El Ministerio de Salud a través de la R.M. Nº 1053-2020/MINSA, publicada el 20 de diciembre del 2020 en el Diario Oficial “El Peruano”, aprobó el Documento Técnico: “Manual de Buenas Prácticas de Farmacovigilancia”, el cual entra en vigencia a los 90 días calendario, contados a partir del día siguiente de la publicación de la mencionada Resolución Ministerial.
La finalidad del citado Manual es contribuir al uso seguro de los productos farmacéuticos, mediante la aplicación de procedimientos operativos y prácticas establecidas que deben seguir los establecimientos farmacéuticos para asegurar la autenticidad y la calidad de los datos de seguridad para la evaluación continua de los riesgos asociados a los productos farmacéuticos.
Mayor información en el enlace de la fuente de referencia.
Full Technical Document: Click aqui
Fuente de referencia: Click aqui
Source: Official Gazette "El Peruano"
Recent posts
El MINSA aprobó el Documento Técnico: Manual de Buenas Prácticas de Farmacovigilancia
MINSA approved the Technical Health Standard that regulates Good Laboratory Practices for Preclinical Studies (GLP-PC) in the Research and Development of Pharmaceutical Products
Extension of the declaration of Sanitary Emergency
The MINSA included in the PNUME for the Health Sector, the product Medicinal Oxygen 93% gas for inhalation
MINSA ordered the publication of the Regulation Project that establishes specific provisions for conducting Clinical Trials with Medical Devices
The MINSA approved the Sanitary Directive for the use of Oxygen in Institutions Providers of Health Services and home use
MINSA approved the Technical Document: National Vaccination Plan against COVID-19
The MINSA orders the publication of the Technical Document project: Manual of Citizen Participation in the elaboration of the PNUME
MINSA approved the Technical Document: Management of people affected by COVID-19 in hospitalization services
MINSA approved the technical document: Guidelines for the exceptional health authorization of medical devices in the research stage
Urgent decree that dictates extraordinary measures to facilitate and guarantee the acquisition, conservation and distribution of vaccines against COVID-19
The MINSA plans to publish a draft ministerial resolution that resolves to include in the PNUME for the health sector, the medicinal oxygen product 93% gas
DIGEMID safety modifications: For pharmaceutical specialties containing "MELOXICAM"
The MINSA approves the update of the scale for infractions and sanctions to pharmaceutical and non-pharmaceutical establishments of the regulation of pharmaceutical establishments
DIGEMID safety modifications: For pharmaceutical products containing "Bacillus Clausii"
DIGEMID safety modifications: For pharmaceutical specialties containing "MONTELUKAST"
DIGEMID safety modifications: For pharmaceutical specialties containing "LORCASERIN"
DIGEMID safety modifications: For pharmaceutical specialties that contain "FENOTEROL"
The MINSA modified the Regulation of Narcotic Drugs, Psychotropic Drugs and Other Substances subject to Sanitary Inspection
The MINSA approved the "Technical Health Standard that establishes the ethical criteria for the promotion and advertising of pharmaceutical products, medical devices and health products"
